Dihydrolipoic acid (DHLA) not only acts as an antioxidant but also an antifibrotic since it has the ability to reverse the profibrotic phenotype of SSc dermal fibroblasts. Also thiol antioxidants, including N-acetylcysteine and LA/DHLA, could be beneficial for patients with SSc. PubMed, Arthritis Res Ther. 2014 Aug 15;16(5):411. (Also see: Lipoic Acid and Skin Fibrosis Research)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.